58551-69-2,MFCD01694769
Catalog No.:AA00E8ZY

58551-69-2 | Prostinfenem

Pack Size
Purity
Availability
Price(USD)
Quantity
  
25mg
95%
1 week  
$128.00   $90.00
- +
50mg
95%
1 week  
$189.00   $133.00
- +
100mg
95%
1 week  
$283.00   $198.00
- +
250mg
95%
1 week  
$453.00   $317.00
- +
1g
95%
1 week  
$1,176.00   $823.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00E8ZY
Chemical Name:
Prostinfenem
CAS Number:
58551-69-2
Molecular Formula:
C25H45NO7
Molecular Weight:
471.6273
MDL Number:
MFCD01694769
SMILES:
CCCCC[C@@](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)OCC(CO)(CO)N)O)(O)C
Properties
Computed Properties
 
Complexity:
527  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
5  
Defined Bond Stereocenter Count:
2  
Formal Charge:
0  
Heavy Atom Count:
34  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
8  
Isotope Atom Count:
0  
Rotatable Bond Count:
15  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  

Downstream Synthesis Route
CASUnavailable 
  77-86-1    58551-69-2 

[1]CurrentPatentAssignee:NANJINGQIYUNGAOHUOPHARMACEUTICALTECH-CN111777537,2020,ALocationinpatent:Paragraph0090;0115-0118;0143-0146;0171-0174;0199-0202

[2]CurrentPatentAssignee:SANOFI-WO2017/93770,2017,A1Locationinpatent:Page/Pagecolumn25

[3]CurrentPatentAssignee:CHIROGATEINTERNATIONAL,INC.;CHIROGATEINTINC;CHIROGATEINTERNATIONALINC-CN115710209,2023,ALocationinpatent:Paragraph0196-0204

[4]CurrentPatentAssignee:CHIROGATEINTERNATIONAL,INC.;CHIROGATEINTINC;CHIROGATEINTERNATIONALINC-US2023/97470,2023,A1Locationinpatent:Paragraph0131-0136

[5]CurrentPatentAssignee:CHIROGATEINTERNATIONAL,INC.;CHIROGATEINTINC;CHIROGATEINTERNATIONALINC-US2023/97470,2023,A1Locationinpatent:Paragraph0131-0142

Literature

Title: [Application of Pfizer drugs in the obstetrics and gynecology practice].

Journal: Akusherstvo i ginekologiia 20090101

Title: Method to determine stability and recovery of carboprost and misoprostol in infusion preparations.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070915

Title: [Some possibilities for application of 'Pfizer' medicines--Prostin 15m, Prostin E2, Prepidil gel, Dostinex, Synarel--in the obstetrician practice].

Journal: Akusherstvo i ginekologiia 20070101

Title: Combined bladder and uterine rupture following prostaglandin-induced midtrimester abortion: an unreported event.

Journal: Acta obstetricia et gynecologica Scandinavica 20031001

Title: Postpartum hemorrhage: new management options.

Journal: Clinical obstetrics and gynecology 20020601

Title: A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage.

Journal: Prostaglandins & other lipid mediators 20011001

Title: Second trimester pregnancy termination in primigravidas by double application of dinoprostone gel and intramuscular administration of carboprost tromethamine.

Journal: Medicinski pregled 20010101

Title: Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine.

Journal: The Journal of urology 19930401

Title: Prophylactic and therapeutic carboprost tromethamine bladder irrigation in rats with cyclophosphamide-induced hemorrhagic cystitis.

Journal: The Journal of urology 19921001

Title: Evaluation of carboprost tromethamine in the treatment of cyclophosphamide-induced hemorrhagic cystitis.

Journal: Cancer 19900715

Title: Ling Z, et al. Effect of carboprost tromethamine in prevention of postpartum hemorrhage in cesarean section. Pak J Pharm Sci. 2018 Sep;31(5(Special)):2257-2262.

Title: Bai J, et al. A comparison of oxytocin and carboprost tromethamine in the prevention of postpartum hemorrhage in high-risk patients undergoing cesarean delivery. Exp Ther Med. 2014 Jan;7(1):46-50. Epub 2013 Nov 1.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:58551-69-2 Molecular Formula|58551-69-2 MDL|58551-69-2 SMILES|58551-69-2 Prostinfenem
Catalog No.: AA00E8ZY
58551-69-2,MFCD01694769
58551-69-2 | Prostinfenem
Pack Size: 25mg
Purity: 95%
1 week
$128.00 $90.00
Pack Size: 50mg
Purity: 95%
1 week
$189.00 $133.00
Pack Size: 100mg
Purity: 95%
1 week
$283.00 $198.00
Pack Size: 250mg
Purity: 95%
1 week
$453.00 $317.00
Pack Size: 1g
Purity: 95%
1 week
$1,176.00 $823.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00E8ZY
Chemical Name: Prostinfenem
CAS Number: 58551-69-2
Molecular Formula: C25H45NO7
Molecular Weight: 471.6273
MDL Number: MFCD01694769
SMILES: CCCCC[C@@](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)OCC(CO)(CO)N)O)(O)C
Properties
Complexity: 527  
Covalently-Bonded Unit Count: 2  
Defined Atom Stereocenter Count: 5  
Defined Bond Stereocenter Count: 2  
Formal Charge: 0  
Heavy Atom Count: 34  
Hydrogen Bond Acceptor Count: 9  
Hydrogen Bond Donor Count: 8  
Isotope Atom Count: 0  
Rotatable Bond Count: 15  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
Downstream Synthesis Route
CASUnavailable 
  77-86-1    58551-69-2 

[1]CurrentPatentAssignee:NANJINGQIYUNGAOHUOPHARMACEUTICALTECH-CN111777537,2020,ALocationinpatent:Paragraph0090;0115-0118;0143-0146;0171-0174;0199-0202

[2]CurrentPatentAssignee:SANOFI-WO2017/93770,2017,A1Locationinpatent:Page/Pagecolumn25

[3]CurrentPatentAssignee:CHIROGATEINTERNATIONAL,INC.;CHIROGATEINTINC;CHIROGATEINTERNATIONALINC-CN115710209,2023,ALocationinpatent:Paragraph0196-0204

[4]CurrentPatentAssignee:CHIROGATEINTERNATIONAL,INC.;CHIROGATEINTINC;CHIROGATEINTERNATIONALINC-US2023/97470,2023,A1Locationinpatent:Paragraph0131-0136

[5]CurrentPatentAssignee:CHIROGATEINTERNATIONAL,INC.;CHIROGATEINTINC;CHIROGATEINTERNATIONALINC-US2023/97470,2023,A1Locationinpatent:Paragraph0131-0142

Literature fold

Title: [Application of Pfizer drugs in the obstetrics and gynecology practice].

Journal: Akusherstvo i ginekologiia20090101

Title: Method to determine stability and recovery of carboprost and misoprostol in infusion preparations.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20070915

Title: [Some possibilities for application of 'Pfizer' medicines--Prostin 15m, Prostin E2, Prepidil gel, Dostinex, Synarel--in the obstetrician practice].

Journal: Akusherstvo i ginekologiia20070101

Title: Combined bladder and uterine rupture following prostaglandin-induced midtrimester abortion: an unreported event.

Journal: Acta obstetricia et gynecologica Scandinavica20031001

Title: Postpartum hemorrhage: new management options.

Journal: Clinical obstetrics and gynecology20020601

Title: A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage.

Journal: Prostaglandins & other lipid mediators20011001

Title: Second trimester pregnancy termination in primigravidas by double application of dinoprostone gel and intramuscular administration of carboprost tromethamine.

Journal: Medicinski pregled20010101

Title: Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine.

Journal: The Journal of urology19930401

Title: Prophylactic and therapeutic carboprost tromethamine bladder irrigation in rats with cyclophosphamide-induced hemorrhagic cystitis.

Journal: The Journal of urology19921001

Title: Evaluation of carboprost tromethamine in the treatment of cyclophosphamide-induced hemorrhagic cystitis.

Journal: Cancer19900715

Title: Ling Z, et al. Effect of carboprost tromethamine in prevention of postpartum hemorrhage in cesarean section. Pak J Pharm Sci. 2018 Sep;31(5(Special)):2257-2262.

Title: Bai J, et al. A comparison of oxytocin and carboprost tromethamine in the prevention of postpartum hemorrhage in high-risk patients undergoing cesarean delivery. Exp Ther Med. 2014 Jan;7(1):46-50. Epub 2013 Nov 1.

Building Blocks More >
65240-86-0
65240-86-0
2-BENZOYLAMINO-1,4-NAPHTHOQUINONE
AA00E96D | MFCD18427708
56341-36-7
56341-36-7
1,5-Dimethylpyrrole-2-carbonitrile
AA00E9D8 | MFCD00003086
62593-17-3
62593-17-3
2-Amino-3,5-dichlorobenzotrifluoride
AA00E9KE | MFCD00174313
63185-86-4
63185-86-4
5-Amino-2-(phenylthio)benzoic acid
AA00E9NY | MFCD06658325
62197-94-8
62197-94-8
(S)-2,2,2-Trifluoro-1-phenylethanamine
AA00E9VX | MFCD06738692
589-37-7
589-37-7
1,3-DIAMINOPENTANE
AA00E9YO | MFCD00134550
58494-59-0
58494-59-0
1-Ethyl-1h-indole-3-carbaldehyde
AA00EA35 | MFCD00047263
63628-26-2
63628-26-2
(R)-(-)-2-Methoxy-2-(1-naphthyl)propionic acid
AA00EAAN | MFCD03093633
58237-94-8
58237-94-8
N-Boc-(3-indole)glycine
AA00EAFK | MFCD03426367
628284-75-3
628284-75-3
6-Fluoro-4-hydroxy-3-nitroquinoline
AA00EAMB | MFCD09800466
Submit
© 2017 AA BLOCKS, INC. All rights reserved.